Cardinal Health, US14149Y1082

Cardinal Health Stock - Analyst consensus after strong run

19.06.2026 - 17:55:11 | ad-hoc-news.de

Cardinal Health stock has delivered a robust multi-year rally. A fresh consensus snapshot shows higher earnings estimates and a solid rating backdrop, while valuation has moved above the industry average.

Cardinal Health, US14149Y1082
Cardinal Health, US14149Y1082

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 17:54 CET. Details in the imprint.

Cardinal Health (US14149Y1082) has seen its stock climb sharply over the past two years. A fresh consensus snapshot compiled by Zacks shows higher earnings estimates and a Buy rating backdrop for the healthcare distributor, even as valuation has moved above the industry average.

Go deeper

All news and analysis on Cardinal Health stock

Key price data, corporate news and further background on Cardinal Health stock are available in the dedicated topic area on ad-hoc-news.de.

What recent research shows

According to a detailed update on Nasdaq.com based on Zacks data, Cardinal Health shares delivered a gain of about 74% in 2025. Year to date, the stock is up a further 7.9%, extending the rally on the back of consistent earnings execution.

The same report highlights that estimates for fiscal 2026 earnings per share have risen by 16.5% over the past year to $10.76, while fiscal 2027 EPS estimates have increased 17.2% to $11.98. Zacks currently assigns the stock a Rank #2, corresponding to a Buy recommendation.

How valuation and peers compare

On valuation, the Nasdaq/Zacks analysis notes Cardinal Health shares trade at a forward 12-month price-to-earnings ratio of about 18.6. That level sits above the cited industry average P/E of 16.15, reflecting investors' willingness to pay a premium for the company’s growth profile.

The report attributes the stronger rating backdrop to several drivers. These include accelerating specialty pharmaceutical distribution, a growing contribution from higher-margin healthcare services and continued improvements in execution across Cardinal Health’s core businesses in a competitive sector.

The product and service engine

Cardinal Health generates most of its revenue from large-scale pharmaceutical distribution to hospitals, pharmacies and other care providers. It also supplies medical-surgical products such as gloves, gowns and syringes, and offers logistics and supply-chain services that support healthcare systems' daily operations.

Where the stock trades today

Cardinal Health shares trade on the New York Stock Exchange under the ticker CAH; the latest available quote referenced in recent analyst commentary showed the stock at $221.77 in regular trading.

Key facts on Cardinal Health stock

  • Company: Cardinal Health Inc.
  • ISIN: US14149Y1082
  • WKN: 879312
  • Ticker: CAH
  • Venue: NYSE
  • Price (as of 06/18/2026, 22:00 CET): 221.77 USD
  • Market cap: 55,000,000,000 USD (as of 06/18/2026)
  • Sector / Industry: Health Care - Healthcare providers and distributors
  • Index membership: Standard & Poor's 500 index
  • Next earnings date: 08/08/2026

More on Cardinal Health stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US14149Y1082 | CARDINAL HEALTH | boerse | 69583938 | bgmi